"As part of Presbyterian Cancer Care, our Presbyterian Medical Group hematology/oncology providers in Albuquerque specialize in the study, diagnoses, and treatment of cancer (oncology) and blood disorders (hematology). In addition to our hematology/oncology clinic, our services include gynecologic oncology, Presbyterian MD Anderson radiation oncology, breast surgery, surgical oncology, and supportive care services. A department of Presbyterian Hospital."

During the past decade, Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 19 clinical trials were completed, i.e. on average, 950% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" #1 sponsor was "SWOG Cancer Research Network" with 6 trials, followed by "New Mexico Cancer Care Alliance" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" are "Breast Cancer" (9 trials), "Cancer" (1 trials), "Cardiac Toxicity" (1 trials), "Chemotherapeutic Agent Toxicity" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" in a lesser frequency.

Most popular intervention types in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" are "Drug" (18 trials), "Biological" (4 trials), "Other" (3 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "pegfilgrastim" (2 trials) and "AC regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital" are 12 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".